GAS6 and breast cancer: Similar to earlier studies associating Gas6 expression with favorable clinical outcome in breast cancer, Gas6 was shown to inhibit intestinal tumorigenesis in a mouse model of intestinal cancer, and Gas6 protein expression in human colorectal cancers positively correlated with prognosis37.